We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -1.62 | -1.64% | 97.44 | 98.22 | 97.44 | 97.76 | 1,562,845 | 01:00:00 |
From Apr 2019 to Apr 2024
By Marc Bisbal Arias
Novartis AG (NOVN.EB) said Monday that it appointed three new members to its executive committee, and that Andre Wyss, president of operations, is leaving the company.
Bertrand Bodson, chief digital officer, and Steffen Lang, global head of technical operations, have been appointed to the company's executive committee.
The Swiss company said that Shannon Klinger's role has been expanded to chief ethics, risk and compliance officer, and she has also been appointed to the executive committee.
All the changes will be effective from April 1.
"The appointments of Bertrand Bodson, Steffen Lang and Shannon Klinger to the ECN will help us accelerate our efforts to lead in data and digital," said Chief Executive Vas Narasimhan.
The company also said that Andre Wyss, president of operations, has decided to leave Novartis.
Novartis Operations will be split into Novartis Technical Operations and Novartis Business Services, it said.
Write to Marc Bisbal Arias at marc.bisbalarias@dowjones.com
(END) Dow Jones Newswires
March 12, 2018 02:58 ET (06:58 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
